We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Qiagen Delivers the Human Druggable Genome siRNA Set

News   Sep 30, 2005

 
Qiagen Delivers the Human Druggable Genome siRNA Set
 
 
 

RELATED ARTICLES

On-chip Drug Screening for Identifying Antibiotic Interactions in Eight Hours

News

A research team developed a microfluidic-based drug screening chip that identifies synergistic interactions between two antibiotics in eight hours. This chip can be a cell-based drug screening platform for exploring critical pharmacological patterns of antibiotic interactions, along with potential applications in screening other cell-type agents and guidance for clinical therapies.

READ MORE

Technology Senses How Parkinson's Patients Respond to Medication

News

Researchers have developed an innovative way to automatically and reliably detect and monitor medication "on" and "off" states in Parkinson's disease patients.

READ MORE

Synthetic Peptide Inhibits Toxicity and Aggregation of Protein in Alzheimer's Disease

News

Alzheimer’s is a disease of aggregation. Neurons in the human brain make a protein called amyloid beta. Now, a team led by researchers at the University of Washington has developed synthetic peptides that target and inhibit those small, toxic aggregates.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE